Brain acetylcholine and gamma-aminobutyric acid (GABA) are both involved in
the regulation of central cardiovascular control. Despite data from anatom
ical and electrophysiological experiments characterizing the interaction be
tween central GABAergic and cholinergic neurotransmission, the potential si
gnificance of this interaction in central cardiovascular regulation remains
unknown. The purpose of this study was to determine whether activation of
GABA(A) receptors by intracerebroventricular or intrahypothalamic administr
ation of muscimol affects the cholinergic agonist-induced cardiovascullar r
esponses. All experiments were performed in conscious, Sprague-Dawley rats
instrumented with a guide cannula for drug injection and iliac arterial cat
heters for direct measurement of mean arterial pressure and heart rate. Adm
inistration of a cholinergic agonist, carbachol, either intracerebroventric
ularly or into the dorsomedial hypothalamic nucleus, produced a significant
increase in mean arterial pressure, whereas injection of carbachol into th
e posterior hypothalamic nucleus caused a slight elevation in blood pressur
e. Pretreatment with muscimol 10 min before administration of carbachol pre
vented the carbachol-evoked blood pressure changes. On the other hand, carb
achol produced variable changes in heart rate, depending on the site of inj
ection. In [H-3]quinuclydinyl benzilate binding experiments, muscimol did n
ot displace the muscarinic radioligand from its binding sites, suggesting t
hat it does not exert any direct antagonistic activity at muscarinic recept
ors. These results suggest that the dorsomedial hypothalamic nucleus is a p
otential site of action for microinjected carbachol and that the GABAergic
system has an inhibitory influence on cholinergic neurons involved in blood
pressure regulation. (C) 1998 Elsevier Science B.V. All rights reserved.